Common Contracts
2 similar Co-Exclusive License Agreement contracts by Wave Life Sciences Pte LTD
EX-10.10 12 d42123dex1010.htm EX-10.10 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Securities Act of 1933, as amended. CONFIDENTIAL CO-EXCLUSIVE LICENSE AGREEMENT between...Co-Exclusive License Agreement • May 5th, 2020
The Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V. (hereinafter “MPG”) is a German non-profit scientific research organisation. At the Max-Planck-Institute for Biophysical Chemistry in Goettingen (“MPI-BC”), a research institute of MPG, Dr. Thomas Tuschl and other scientists of MPI-BC have discovered the sequence and structural features of single-stranded RNA molecules required to mediate target-specific nucleic acid modifications by RNA interference ([***]). The aforementioned invention was funded by the German government. MPG has filed certain Patent Rights (as later defined herein) relating thereto.
CONFIDENTIAL CO-EXCLUSIVE LICENSE AGREEMENT between Max-Planck-Innovation GmbH a German corporation having a principal place of business at Amalienstr. 33, 80799 Muenchen, Germany - hereinafter “MI” - and Wave Life Sciences PTE, Ltd. a Singapore...Co-Exclusive License Agreement • October 9th, 2015 • Wave Life Sciences Pte LTD • Pharmaceutical preparations
The Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V. (hereinafter “MPG”) is a German non-profit scientific research organisation. At the Max-Planck-Institute for Biophysical Chemistry in Goettingen (“MPI-BC”), a research institute of MPG, Dr. Thomas Tuschl and other scientists of MPI-BC have discovered the sequence and structural features of single-stranded RNA molecules required to mediate target-specific nucleic acid modifications by RNA interference ([***]). The aforementioned invention was funded by the German government. MPG has filed certain Patent Rights (as later defined herein) relating thereto.
